Conclusion: Initial assessment of the process of mobilizing CD34+ hematopoietic stem cells from bone marrow to peripheral blood in patients with multiple myeloma at 108 Military Central Hospital by Cyclophosphamide + G-CSF regimen is relatively safe and achieve high efficiency.